Compositions and methods for transdermal oxybutynin therapy

Details for Australian Patent Application No. 2003287377 (hide)

Owner Watson Pharmaceuticals, Inc.

Inventors Ebert, Charles D.; Sanders, Steven W.

Agent FB Rice

Pub. Number AU-B-2003287377

PCT Number PCT/US2003/0346

PCT Pub. Number WO2004/041188

Priority 10/286,381 01.11.02 US

Filing date 31 October 2003

Wipo publication date 7 June 2004

Acceptance publication date 25 February 2010

International Classifications

A61K 31/195 (2006.01)

A61F 13/00 (2006.01) Bandages, dressings or absorbent pads

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/06 (2006.01) Medicinal preparations characterised by special physical form - Ointments

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 31/216 (2006.01)

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 9/70 (2006.01) Medicinal preparations characterised by special physical form - Web, sheet or filament bases

Event Publications

1 April 2004 Complete Application Filed

  Priority application(s): 10/286,381 01.11.02 US

1 July 2004 Application Open to Public Inspection

  Published as AU-B-2003287377

25 February 2010 Application Accepted

  Published as AU-B-2003287377

24 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003287378-AMINOCYCLOHEXYL ETHER COMPOUNDS AND USES THEREOF

2003287376-ANTI-ANGIOGENESIS EFFECTS OF MORINDA CITRIFOLIA